Imagine a world where European healthcare challenges are met with powerful new tools that improve patient outcomes, streamline healthcare processes, and relieve pressures on overburdened systems. In 2024, this is no longer a distant vision—it's happening today, driven by the rapid evolution of AI and data-driven technologies across Europe.
According to recent market research, the European digital health market, valued at EUR 61.1 billion in 2023, is projected to grow at an impressive compound annual growth rate (CAGR) of 22.3% from 2024 to 2030. This remarkable growth underscores the increasing importance of AI and data-driven solutions in addressing healthcare challenges.
Let's dive into some of the standout companies making waves in AI and data-driven healthcare this year. These innovators are reimagining diagnostics, enhancing surgical precision, and expanding access to life-saving tools, all to build a healthier future for patients across Europe.

Siemens Healthineers (Germany)
Leading the way in medical technology is Siemens Healthineers, With AI-powered imaging and diagnostic solutions. Their AI-Rad Companion platform, a comprehensive AI-powered tool supporting radiologists across multiple specialities, provides deep insights through AI-assisted analysis of complex imaging data. This year, they advanced their "digital twin" technology, allowing clinicians to create virtual patient models based on diagnostic data—bringing personalised treatment planning closer than ever before.
Stryker (Netherlands/USA)
Though headquartered in the US, Stryker's European team has made impressive progress with AI-driven surgical technology. Their Mako robotic-arm, now enhanced with machine learning, assists orthopaedic surgeons in achieving incredible precision. Stryker's AI tools also offer predictive analytics for post-operative care, helping reduce complications and ensuring patients experience smoother recoveries.
Mimetas (Netherlands)
Mimetas has transformed drug discovery with its groundbreaking Organ-on-a-Chip technology. In 2024, they introduced AI-driven data analysis for their 3D cell culture models, accelerating drug screening and providing new insights into drug efficacy and safety. This integration allows researchers to predict how drugs will behave in human tissues, making strides toward truly personalised medicine.
Thirona (Netherlands)
Thirona is making a tangible difference in medical imaging. Their LungQ software, which uses deep learning to analyse chest CT scans, has become a vital tool for pulmonologists. Expanding in 2024, they introduced AI solutions for retinal image analysis, providing early detection capabilities for eye diseases and meeting the growing demand for accessible, proactive eye health.
ScreenPoint Medical (Netherlands)
Screenpoint Medical's Transpara software for breast cancer screening is already an essential tool, but this year it became even more powerful. With a new update in 2024, Transpara can now predict breast cancer risk years in advance, allowing for earlier, more targeted interventions that can save lives.
Delft Imaging (Netherlands)
Delft Imaging is democratising access to diagnostics through AI-powered imaging solutions. Their portable X-ray devices equipped with AI for tuberculosis detection are widely used in underserved areas. In 2024, they expanded their AI capabilities to detect a broader range of lung conditions, ensuring more patients can access accurate diagnostics no matter where they live.
Okra.ai (UK)
Okra.ai has revolutionised pharmaceutical operations with its AI insights platform. This year, they unveiled a natural language processing module that interprets real-world data, enabling pharmaceutical companies to understand drug performance in actual patient populations. Okra's work is shaping the future of precision medicine by helping companies create targeted treatments that address patients' unique needs.